Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc while Breastfeeding

What is Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc ?

Can I use Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc while breastfeeding?

Echinacea angustifolia while Breastfeeding

CAS Number: 84696-11-7

Plant that is widely used even during pregnancy and breastfeeding. Because a lack of toxicity with an appropriate dose and moderate consumption it should be compatible with breastfeeding. The roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids among others. Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications are: common cold, bronchitis, skin lesions.Roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids ... Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications according to Commission E of German Ministry of Health: common cold, bronchitis, skin lesions. Contrary to the European Scientific Cooperative on Phytotherapy (ESCOP), the European Medication Agency does not recommend usage in younger than 12 years (allergy risk). Avoid using for longer than 8 weeks (risk for leukopenia)

Echinacea purpurea while Breastfeeding

CAS Number: 84696-11-7

Plant that is widely used even during pregnancy and breastfeeding. Because a lack of toxicity with an appropriate dose and moderate consumption it should be compatible with breastfeeding. The roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids among others. Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications are: common cold, bronchitis, skin lesions.Roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids ... Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications according to Commission E of German Ministry of Health: common cold, bronchitis, skin lesions. Contrary to the European Scientific Cooperative on Phytotherapy (ESCOP), the European Medication Agency does not recommend usage in younger than 12 years (allergy risk). Avoid using for longer than 8 weeks (risk for leukopenia)

Aconitum napellus while Breastfeeding

The flowers and roots and leaves of this herbaceous plant are used. It contains sesquiterpene lactones, essential oil, flavonoids and traces of pyrrolizidine alkaloids. Topical use on whole skin. Indications in traditional medicine without evidence of its effectiveness: topical anti-inflammatory in bruises, sprains and localized muscle pain (EMA 2014). Do not apply to damaged skin It is very toxic orally (Anderson 2017), having described gastroenteritis, cardiac arrhythmia, neurological problems and death (WHO 2007 p.77, nal 2001) in people who took it and a case of severe hemolytic anemia in 9-day-old newborn whose mother was taking arnica infusion (Miller 2009). At the date of the last update, we did not find published data on its excretion in breast milk. The small dose and poor plasma absorption of most topical dermatological preparations make it unlikely that a significant amount will pass into breast milk. Do not apply on the breast so that the infant does not ingest it, or in large areas or for prolonged periods to avoid systemic absorption. Hands should be washed after applying arnica to avoid possible contact with the infants mouth.

Arnica montana while Breastfeeding

CAS Number: 977000-27-3

Se utilizan las flores y también raíces y hojas de esta planta herbácea.Contiene lactonas sesquiterpénicas, aceite esencial, flavonoides y trazas de alcaloides pirrolizidínicos.Uso tópico sobre piel íntegra.Indicaciones en medicina tradicional sin pruebas de su eficacia: antiinflamatorio tópico en contusiones, esguinces y dolores musculares localizados (EMA 2014). No aplicar sobre piel dañada.Es muy tóxica por vía oral (Anderson 2017) habiéndose descrito gastroenteritis, arritmia cardiaca problemas neurológicos y muerte (WHO 2007 p.77, n.a.l. 2001) en personas que la tomaron y un caso de anemia hemolitica grave en un recién nacido de 9 días cuya madre tomaba infusión de arnica (Miller 2009). A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna. La pequeña dosis y la escasa absorción plasmática de la mayoría de preparaciones dermatológicas tópicas  hacen poco probable el paso de cantidad significativa a leche materna. No aplicar sobre el pecho para que el lactante no lo ingiera, ni en áreas extensas o por periodos prolongados para evitar absorción sistémica. Conviene lavarse las manos después de la aplicación de arnica para evitar un posible contacto con la boca del lactante.

Calendula officinalis flowering top while Breastfeeding

CAS Number: 977001-93-6

The inflorescences of this plant originating in Europe are used.It contains polysaccharides, flavonoids, saponins… Attributed properties which do not have sufficient clinical evidence to support them: healing agent, antiseptic, anti-inflammatory (local, dermatological). There is no evidence of its efficacy when taken orally to treat gastrointestinal disorders. Indications from the Commission E of the German Ministry of Health and the EMA: topical treatment of minor skin inflammations, ulcers and burns. Since the last update we have not found any published data on its excretion in breast milk. A plant devoid of toxicity. Oral use during breastfeeding is not advised (EMA 2008, Amir 2011).The small dose and poor plasma uptake of most topical dermatological preparations make it very unlikely that significant amounts will pass into breast milk. There is no evidence of its effectiveness in treating nipple cracking or inflammation. If applied to the breast, do so after breastfeeding and clean before the next feed.

Hamamelis virginiana root bark/stem bark while Breastfeeding

CAS Number: 68916-39-2

Leaves of the plant and sometimes bark also are used. It contains tannins, pro anthocyanidins and flavonic heterosides (quercitrin, isoquercitrin). Venous-tonic and anti-inflammatory properties have not been well established. The Commission E of the German Ministry of Health authorizes its use locally and by suppositories.

Atropa belladonna while Breastfeeding

CAS Number: 8007-93-0

In herbal medicine the leaves of this plant that contains numerous alkaloids are used: l-hyoscyamine and atropine, scopolamine or hyoscine and, all of them potentially high toxic.Traditionally used with poor clinical evidence based on trials as anti-asthmatic, for common colds and intestinal spasms. At latest update no published data on excretion into breast milk were found. With anticholinergic and antimuscarinic properties that may reduce milk production: if necessary take as low dose as possible and avoid long-term treatment if decreasing milk production is observed.Serious side effects (tachycardia, thirst, fever, mydriasis, seizures, coma), especially in infants and newborns (Caksen 2003 Laffargue 2011, Glatstein 2014, Rodríguez-González 2014).There have been cases of gangrene when applied to the chest (Wani 2011). Belladonna may be included in association with other “over the counter" medications of doubtful effectiveness or safety. Overall drug associations are not recommended. Cautions when taking herbal teas:1. Make sure it is obtained from a reliable source: reportedly, poisonings have occurred due to confusion after using another plant with toxic effects (Hsu 1995), some others contain heavy metals that may cause poisoning and others may cause food poisoning due to contamination with bacteria or fungi.2. Do not take it excessively. "Natural" products are not always good in any amount: plants contain active substances from which are made many compounds of our traditional pharmacopoeia that can cause poisoning if consumed in exaggerated quantities or for long periods.

Chamomile while Breastfeeding

CAS Number: 520-36-5

It is a widely used plant even in infants. Because of lack of toxicity, a moderate use is considered to be safe. If topically used, do not apply it on the nipple because risk of contact dermatitis has been reported. There are two different species with similar properties: 1) Common or Sweet Chamomile (Matricaria recutita or Chamomilla recutita). 2) Roman, English or Bitter Chamomile (Anthemis nobilis o Chamaemelum nobile). Inflorescence of the herb is used. Contains Essential Oil, Flavonoids, Lactones and Tannins. Unproven properties are: Anti-spasmodic. Digestive, Anti-inflammatory, Sedative.

Hypericum oil while Breastfeeding

CAS Number: 68917-49-7

Herb commonly used from ancient times. Firm evidence is available on its effectiveness for treatment of depression, to the extent that it should be avoided a sudden stop of medication to prevent a rebound effect. It has been also topically used for the treatment of wounds, burns and eczema due to healing and antiseptical properties. Constituents are: Hypericin, Hyperforin and Quercetin. Antidepressant properties are attributed to Hypericin but mostly to Hyperforin. Quercetin is a flavonoid which is commonly found in many fruits and eatable vegetables. Hyperforin is excreted into breast milk in nil or clinically non-significant amount with not side-effects reported among breastfed infants from treated mothers, except for isolated and dubious cases of somnolence and colicky pain with spontaneous resolution with no medical intervention being required. Plasma levels in those infants were undetectable or close to the lower detectable point (0.1μg/L). Hypericin has not been detected in the breast milk. Quercetin levels found were as low as of few nanomols/L., and related to composition of fruits and vegetables of diet. It is most important to make sure that composition and amount of Hypericum contained in commercially available products is correct, do not take it without medical surveillance, avoid sudden stop and consider pharmacological interactions with many other medications.

Comfrey root while Breastfeeding

CAS Number: 84696-05-9

Roots and leaves are used. It contains allantoin, tannins, and pyrrolizidine alkaloids. Unproved effect: topical anti-inflammatory. Indications after Commission E of German Ministry of Health: contusion with undamaged skin. Do not apply on the breast. Pyrrolizidine alkaloids are highly hepatotoxic and poses an increased risk of liver carcinoma and cirrhosis to both the mother and the infant. Consider not to use it at all.

Colchicine while Breastfeeding

CAS Number: 64-86-8

It is used for treatment of Gout, Familial Mediterranean Fever. As well as for other conditions like Amyloidosis, Behçet's Syndrome, Pericarditis, Primary Biliary Cirrhosis and Pyoderma gangrenosum. It is excreted in breast milk in quantities that differ according to different published studies, from no clinically significant in some, until being important in others, but there have been no problems in infants whose mothers were treated, even after months, with undetectable plasma levels in these infants. The concomitant use of macrolide antibiotics and fruit juices (both the mother and the infant) , especially grape-fruit, is not recommended since they may interfere with bile excretion and greatly increase toxicity. The American Academy of Breastfeeding rates it as compatible with breastfeeding. List of Essential Medicines of WHO (2002): compatible with breastfeeding

Echinacea angustifolia while Breastfeeding

CAS Number: 84696-11-7; 90028-20

Echinacea species (Echinacea angustifolia, Echinacea purpurea, Echinacea pallida) contain high molecular weight polysaccharides (e.g., heteroxylan, arabinogalactan) and lower molecular weight compounds (e.g., alkylamides, caffeoyl conjugates such as cichoric acid and echinacosides), but no single chemical is known to be responsible for echinacea's biological activity. Some products have been standardized based on echinacoside, and others on cichoric acid. Echinacea has no specific uses during breastfeeding, but is commonly used orally to treat or prevent upper respiratory infections. It is also used topically to treat skin infections. Excretion of some of the purportedly active alkamides was found in breastmilk in one mother. No data exist on the safety and efficacy of echinacea in nursing mothers or infants. In general, echinacea is well tolerated with gastrointestinal upset, diarrhea and constipation, skin rash and rarely allergic reactions reported. It may also alter the metabolism of some dugs metabolized by the P450 enzyme system. Some sources indicate that echinacea is safe in recommended doses,[1] while others recommend avoiding it during breastfeeding because of the lack of published safety data. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Echinacea purpurea while Breastfeeding

CAS Number: 84696-11-7; 90028-20

Echinacea species (Echinacea angustifolia, Echinacea purpurea, Echinacea pallida) contain high molecular weight polysaccharides (e.g., heteroxylan, arabinogalactan) and lower molecular weight compounds (e.g., alkylamides, caffeoyl conjugates such as cichoric acid and echinacosides), but no single chemical is known to be responsible for echinacea's biological activity. Some products have been standardized based on echinacoside, and others on cichoric acid. Echinacea has no specific uses during breastfeeding, but is commonly used orally to treat or prevent upper respiratory infections. It is also used topically to treat skin infections. Excretion of some of the purportedly active alkamides was found in breastmilk in one mother. No data exist on the safety and efficacy of echinacea in nursing mothers or infants. In general, echinacea is well tolerated with gastrointestinal upset, diarrhea and constipation, skin rash and rarely allergic reactions reported. It may also alter the metabolism of some dugs metabolized by the P450 enzyme system. Some sources indicate that echinacea is safe in recommended doses,[1] while others recommend avoiding it during breastfeeding because of the lack of published safety data. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Calendula officinalis flowering top while Breastfeeding

CAS Number: 84776-23-8; 70892-20

Calendula (Calendula officinalis) flowers contain triterpene glycosides and aglycones, carotenoids, and essential oils. Topical application of calendula products has been used to treat sore and cracked nipples during nursing, either in homeopathic or pharmacologic preparations,[1][2][3] although little high-quality evidence supports this use.[4] One uncontrolled case series found that a cream containing Mimosa tenuiflora and Calendula officinalis was useful for healing cracked nipples during breastfeeding;[5] however, the lack of a control group and the presence of another ingredient makes the evaluation of calendula's efficacy impossible. Oral calendula has no specific lactation-related uses and no information is available on the oral use of calendula during breastfeeding. Calendula is "generally recognized as safe" (GRAS) as a food by the U.S. Food and Drug Administration when used as a seasoning or flavoring. Allergic reactions, including cross-reactions to chrysanthemums, daisies and marigolds, occur rarely. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Atropa belladonna while Breastfeeding

CAS Number: 8007-93-0

Belladonna (Atropa belladonna) contains anticholinergic alkaloids such as atropine and scopolamine. Belladonna has been used in the past for headache, airway obstruction, and irritable bowel syndrome among others, but its use has been supplanted by more specific and less toxic compounds. Long-term use of belladonna might reduce milk production by reducing serum prolactin.[1] Application of belladonna paste to the nipple to reduce milk secretion during lactation is an extremely old use.[2] However, it is still used this way in rural India for treating breast abscesses and may have contributed to cases of breast gangrene.[3] Because of the narrow therapeutic index and variable potency of plant-based (i.e., nonstandardized) belladonna, it should be avoided orally and topically during lactation. Homeopathic products are not likely to interfere with breastfeeding or cause toxicity. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Chamomile while Breastfeeding

CAS Number: 8002-66-2

Two different plant species with similar effects are known as chamomile: German chamomile (Matricaria recutita) and Roman chamomile (Chamaemelum nobile). Both contain similar ingredients, including sesquiterpenes (e.g., bisabolol, farnesene), sesquiterpenelactones (e.g., chamazulene, matricin), flavonoids (e.g., apigenin, luteolin), and volatile oils. Chamomile is used orally as a sedative and for gastrointestinal conditions; it is used topically for wound healing. Both herbal and homeopathic preparations have been used to treat mastitis and cracked, bleeding nipples.[1] Chamomile has been used as a galactogogue;[2][3] however, no scientifically valid clinical trials support this use. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production.[4] Chamomile is "generally recognized as safe" (GRAS) for use in food by the U.S. Food and Drug Administration as a spice, seasoning, or flavoring agent. No data exist on the safety of chamomile in nursing mothers or infants, although rare sensitization may occur (see below).[5] It has been safely and effectively used alone and with other herbs in infants for the treatment of colic, diarrhea, and other conditions,[6][7][8][9] so the smaller amounts expected (but not demonstrated) in breastmilk are likely not to be harmful with usual maternal doses. Note Clostridium botulinum (botulism) spores have been found in some loose-leaf chamomile teas sold in health food stores. Topical chamomile is a known sensitizing agent, even with homeopathic products.[10] Two women developed contact dermatitis of the nipples and areolas after applying Kamillosan ointment for cracked nipples. The product was purchased in England and contained 10.5% Roman chamomile extracts and oil. Reactions were confirmed to be caused by Roman chamomile by patch testing in both women. Drinking chamomile tea can exacerbate topical skin rashes and has caused anaphylaxis in sensitized individuals.[11] Chamomile has possible cross-reactivity with other members of the aster family (e.g., echinacea, feverfew, and milk thistle).[5] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Comfrey root while Breastfeeding

CAS Number: 84696-05-9

Comfrey (Symphytum officinalis) herb and leaf contains allantoin and rosmarinic acid; comfrey also contains pyrrolizidine alkaloids. Comfrey preparations have been used topically for pain following episiotomy and cracked, painful nipples, either as aqueous preparations or in creams and ointments.[1][2][3][4][5][6][7] Scientific evidence of effectiveness for these indications is minimal. The pyrrolizidine alkaloids in comfrey can cause severe liver damage, liver cancer, mutagenicity, and even death.[8][9] For this reason, the U.S. Food and Drug Administration has banned the sale of oral comfrey products in the United States. Furthermore, most sources consider topical use of comfrey during breastfeeding to be contraindicated.[1][10][11] If it is used on the skin, it should only be applied to intact skin away from the breast on the smallest area of skin possible, and for a limited duration. It is particularly important to ensure that the infant not come into direct contact with the areas of skin that have been treated, because ingestion may cause severe liver damage. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Colchicine while Breastfeeding

CAS Number: 64-86-8

Long-term prophylactic maternal doses of colchicine up to 1.5 mg daily produce levels in milk that result in the infant receiving less than 10% of the maternal weight-adjusted dosage. The highest milk levels occur 2 to 4 hours after a dose, so avoiding breastfeeding during this time can minimize the infant dose, although some clinicians simply recommend taking the drug after nursing. No adverse effects in breastfed infants have been reported in case series and a case-control study and some authors consider colchicine safe during breastfeeding in women being treated for familial Mediterranean fever or rheumatic conditions.[1][2][3][4]

What should I do if I am breastfeeding mother and I am already exposed to Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc?

My doctor has prescribed me Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc, what should I do?

If I am using Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Tranzgel | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc in breastfeeding?